Screener
CG Oncology CGON Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from CG Oncology’s reported figures.
The source filing: CG Oncology’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336918
FAQ
- What is CG Oncology's invested capital?
- CG Oncology (CGON) reported invested capital of $1.02B in Q2 2026.
- How has CG Oncology's invested capital changed year-over-year?
- CG Oncology's invested capital increased by 55.1% year-over-year, from $656.73M to $1.02B.
- What is the long-term trend for CG Oncology's invested capital?
- Over 2 years (2023 to 2025), CG Oncology's invested capital has grown at a 135.7% compound annual growth rate (CAGR), from -$130.91M to $727.13M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about CG Oncology's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude